Should aortas in patients with bicuspid aortic valve really be resected at an earlier stage than tricuspid? CON.

Michael A. Coady, Philip H. Stockwell, Michael P. Robich, Athena Poppas, Frank W. Sellke

Research output: Contribution to journalComment/debatepeer-review

Abstract

Bicuspid aortic valve (BAV)-associated aortopathy is a complex phenomenon, and the current lack of univocal interpretation of its causes and treatment can be ascribed to the multiform nature of its clinical presentation. Although there is strong bias in the literature favoring more aggressive treatment of ascending aortic dilatation in patients with BAV, evidence supporting this opinion is lacking. This review discusses some of the relevant issues relating to causation to facilitate a better analysis of the current recommendations used to guide surgical management, and concludes that treatment should be tailored by individual valvular pathology, clinical phenotype, and relevant comorbidities, using well-documented evidence-based clinical size criteria.

Original languageEnglish (US)
Pages (from-to)299-314
Number of pages16
JournalCardiology clinics
Volume28
Issue number2
DOIs
StatePublished - May 2010
Externally publishedYes

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint

Dive into the research topics of 'Should aortas in patients with bicuspid aortic valve really be resected at an earlier stage than tricuspid? CON.'. Together they form a unique fingerprint.

Cite this